Buy dimenhydrinate

Dimenhydrinate

It has not been firmly established whether these arrhythmias are primary arrhythmias or whether some are secondary to acute coronary ischaemia or indicate in situ coronary thrombosis.

Dimenhydrinate drug

Prolonged penile erection seldom associated with sexual arousal right of the patient to withhold information that is communicated between the patient and health care provider, for instance, dimenhydrinate wiki. However, so far the quantitative effect of dimenhydrinate in the prophylaxis of postoperative nausea and vomiting ponv ; has not been evaluated systematically.
The distribution in Figure 2 shows that the "best" discount card offers average savings of 24.4 percent, or .04 per prescription. All of the cards in the top quartile provide savings of at least 19.9 percent, and the median card offers savings of 17.2 percent, or .48 per prescription. A beneficiary who chooses a good value card among the top nine ; can expect savings of at least 9 over 18 months. In contrast, a few cards at the other end of the distribution provide savings of less than 0, or 11.5 percent, over 18 months. Table 2 in the Appendix of this document details the amount of dollar savings per prescription and per capita for each of the 34 cards represented in the figure below. Figure 2. Savings for Each Discount Card Sponsor Offering Top 25 Drugs Nationally, for example, side effects of dimenhydrinate. Hypersensitivity to dimenhydrinate, diphenhydramine or propylene glycol present in 50 mg ml preparation only. Optimal semiquantitative RT-PCR conditions for prepro-orexin, OX1-R, and OX2-R and G3PDH primers reported herein were determined by the strategy described previously 25 ; . Briefly, 1.0 g total RNA was reverse transcribed in a final volume of 20 l containing 4 l 5 reverse transcriptase buffer [0.1 m Tris-HCl pH 8.8 ; , 0.5 m KCl, and 1% Triton X-100], 5 mm MgCl2, 10 mm dithiothreitol, 0.625 mm of each deoxy d ; -NTP, 20 U RNasin, 1 l 50 m random hexamers, and 200 U SuperScript II RNase H reverse transcriptase Life Technologies, Inc. Grand Island, NY ; . The RT mixtures were incubated at 42 C for 1 h and then heated at 95 C for 5 min to inactivate the reverse transcriptase. Amplification of 4 l mixture equivalent to 0.2 g total RNA ; was carried out with 5 l 10 PCR buffer 0.5 mm KCl and 0.1 mm Tris-HCl, pH 8.3 ; , 4.0 l 25 mm MgCl2, 1.0 l 12.5 mm dNTP, 1 Ci [32P]dATP Amersham Pharmacia Biotech, Arlington Heights, IL ; , 1 l sense or antisense primers 0.1 g l ; , and 2.5 U AmpliTaq DNA polymerase in a total volume of 50 l. The RT-PCR reactions were initially denatured at 94 C for 3 min and then subjected to cycles of denaturation 94 C, 45 sec ; , annealing 60 C, 45 sec ; , and extension 72 C, 45 sec ; . The number of amplification cycles was 20 for prepro-orexin, 28 for OX1-R and OX2-R, and 25 for G3PDH. After the last cycle, the extension was continued for another 7 min at 72 C. 15- l sample was resolved on composite gels of 1.5% NuSieve GTG FMC Bioproducts, Rockland, ME ; and 1% agarose containing 25 l ethidium bromide 500 g ml ; . The expression level of each gene of interest in samples was measured by scintillation counting of radioactivity incorporated into the amplified products using a liquid -scintillation spectrometer Beckman Coulter, Inc., Palo Alto, CA ; , or image-quantitative analysis of the amplified RT-PCR products. The primer sequences used for PCR amplification of prepro-orexin, OX1-R, and OX2-R genes and the expected respective PCR product sizes are shown in Table 1 and ditropan.
The CHMP assessment report of the medicinal product and the reasons for the favourable CHMP scientific opinion will be made available on the EMEA website : emea .int ; , after consulting the applicant on deletion of any information of a commercially confidential nature. This document is called the European Public Assessment Report EPAR ; on a scientific opinion in cooperation with WHO. Abstract The over-the-counter anti-emetic dimenhydrinate DMH ; Gravol or Dramamine ; has been reported to be abused for non-medicinal purposes. Street drug users abuse DMH for the acute effects of euphoric sensations and hallucinations, while psychiatric patients abuse DMH for its anxiolytic or anti-cholinergic effects. DMH is an H1 histamine receptor antagonist, but it interacts either directly or indirectly with other neurotransimitter systems, including those using acetylcholine, serotonin, norepinephrine, dopamine, opioids or adenosine. Animal behavioural studies, such as self-administration, conditioned place preference, drug discrimination, and modulation of operant responding, show that anti-histamines have abuse potential. Further support comes from reports of acute and chronic abuse of DMH by humans. Collectively, results conrm the abuse liability of DMH. q 2002 Published by Elsevier Science Ltd and dramamine. Brand-name medication expected to become available generically during 2005. After the generic medication becomes available, the brandname medication may be covered at a higher copay and or added to the Formulary Exclusions List.
In selected settings. The technique of circular vection has been used to evoke tachyarrhythmias, which are blocked by atropine and blunted by phentolamine, indicating mediation by cholinergic neural pathways and modulation by -adrenoceptor pathways 9 ; . Other investigations have demonstrated prevention of tachygastria with motion sickness after pretreatment with accepted treatments for this condition, including the antimuscarinic agent scopolamine and the antihistamine drug dimenhydrinate. Similarly, the serotonin 5-HT3 receptor antagonist ondansetron prevents bradygastria evoked by opiate administration and reduces tachyarrhythmias associated with experimental motion sickness. Finally, eradication of H. pylori infection is associated with reductions in tachygastria in the subset of functional dyspepsia patients with underlying gastric dysrhythmias 30 ; . However, correlations of slow-wave stabilization with reductions in nausea and vomiting during treatment with prokinetic or antiemetic drugs do not prove that the beneficial therapeutic action of these agents stems from a specific antiarrhythmic effect. Such a conclusion awaits investigative confirmation and enalapril.
Blockers like timolol or propanolol, antihistamines like buclizine or dimenhydrinate, ergot alkaloids like ergotamine and dihydroergotamine, analgesics like acetaminophen, diclofenac propyphenazon, non-steroidal antiphlogistics like acetylsalicylic acid, naproxen or ibuprofen. Department of chemistry, clemson university, clemson, sc 29634, usa department of pharmacology and toxicology, medical college of virginia campus, virginia commonwealth university, richmond, va 23298, usa and escitalopram.

Comparable to Dramamine. Active ingredient: Dimenhydrinate, 50 mg. Aids in the prevention of motion sickness. The only thing I knew. I didn't know the value of honesty." Warnecke says that for years she also was in denial. "I wanted them to fix me. What I know now is invaluable. The skills I've learned will save my life." As she incorporated into her daily life such skills as emotion regulation, interpersonal communication, and distress tolerance, techniques she learned from years of group therapy, Warnecke had better control of her life. Dialectical Behavior Therapy DBT ; , an innovative treatment model created to treat borderline personality disorder, has been instrumental in her success. This method teaches individuals the coping skills and adaptive solutions to deal with their intense surges of emotion. The goal is to self-regulate emotion to reduce crises, suicide attempts, and patterns of self-mutilation as a means of coping with intense and painful feelings. SIRSS offers both individual and group therapy for delivering DBT services. Participants receive peer support and skills training in group therapy, and they can work on their personal goals with individual therapy. "My biggest dream is to give back what I have received, " says Warnecke. "Have you heard the term `pay it forward'?" she asks, referring to a concept central to the 2000 Hollywood movie by the same name starring Haley Joel Osment, Helen Hunt, and Kevin Spacey ; . When someone does you a big favor, don't pay it back, pay it forward, she explains. Repaying good deeds with new good deeds directed to other people can create positive change in the world. Warnecke is doing just that. She was the first president for the Board of Volunteers of the Franklin-Williamson Human Services Drop-In Center, and has been a guest speaker addressing mental illness issues at the Illinois Consumer Conference, at Southern Illinois University Carbondale psychology classes, and at the SIUC Police Department's sensitivity training sessions. Warnecke now serves as a peer counselor and a WRAP Wellness Recovery Action Planning ; facilitator at SIRSS. Warnecke also has established personal goals, using her new-found skills to make a deal with her psychiatrist. If she remained stable for one year with no hospitalizations, her psychiatrist would serve as her payee for social security, which for Warnecke translated into independence. Warnecke not only achieved that goal, but she has been her own payee for three years. Her dream is to finish her bachelor's and master's degrees in psychology, become financially independent, and, ultimately, become a motivational speaker. Says Warnecke, "I want to pay it forward and esomeprazole. TABLE 2. White blood cells WBC ; WBC Granular Neutrophils Basophils Eosinophils Lymphocytes Monocytes, for example, dimenhydrinate.

A synthetic secretin stimulated endoscopic pancreatic function test was carried out in 16 healthy volunteers and 14 patients with established chronic pancreatitis and trypsin 20 IU L and 7 with established chronic pancreatitis and trypsin 20 IU L. The authors concluded that by measuring total HCO3 output instead of peak quantification HCO3, the 1-hour endoscopic pancreatic function test can be modified to establish the degree of pancreas exocrine insufficiency, normal value in the range of 6000 mEq and pancreatic insufficiency in the range of 2000 mEq [31]. Significantly abnormal nasal potential difference measurements in the diagnosis of idiopathic chronic pancreatitis were observed after pharmacological stimulation, reflecting abnormal chloride secretion and possibly explaining the pancreatic symptoms. The authors recommended this easy and inexpensive test before genetic testing since mutational screening of the entire CFTR gene cannot be considered in every patient with idiopathic pancreatitis [32]. In a prospective, blinded study of the relationship between serum amylase lipase and pancreatic EUS in 951 patients it was shown that idiopathic, asymptomatic hyperamylasemia and hyperlipasemia were associated with chronic pancreatitis diagnosed with EUS. However, no other significant pathology was found in these patients [33]. On the other hand, Lankisch et al. found that among 1293 consecutive patients admitted as an emergency to a gastroenterological department, 14% had hyperamylasemia n 14 ; or hyperlipasemia n 117 ; or both n 44 ; . these, 39% finally had defined diagnosis: acute or chronic pancreatitis or pancreatic cancer n 28 ; or another tumor n 10 ; or renal insufficiency n 31 ; . The remaining 61% of patients had no abdominal signs or symptoms indicative of acute pancreatitis. However, in 20% of these patients a final diagnosis of chronic pancreatitis or bile duct disease was made [34] and estrace. 85 C Silagy, T Lancaster, L Stead, D Mant, G Fowler: Cochrane review: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2002; 4; 1-98 T Lancaster, LF Stead: Cochrane review: Self-help interventions for smoking cessation. Cochrane Database Syst Rev 2002; 4; 1-57 A Cepeda-Benito: Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. J Cons Clin Psychology 1993; 61; 5; JE Rose: Nicotine addiction and treatment. Annu Rev Med 1996; 47; 493-507 P Tnnesen: Smoking cessation: nicotine replacement, gums and patches. Monaldi Arch Chest Dis 1999; 54; 6; A Jessen, S Toubro, A Astrup: The effect of a nicotine and caffeine chewing gum on energy expenditure in lean non smoking males. Int J Obesity 2002; 26; 97 A Jessen, S Toubro, A Astrup: The effect of a nicotine and caffeine chewing gum on appetite in lean non smoking males. Int J Obesity 2002; 26; 158 AB Jessen, S Toubro, A Astrup: The effect of chewing gum with nicotine and caffeine on energy expenditure and substrate utilisation in men. J Cl Nutrition, submitted 93 DW Woodford, LJ Lesko: Relative bioavailability of aspirin gum. J Pharm Scie 1981; 70; 12; E Bousquet, S Tirendi, FP Bonina, L Montenegro, A Bianchi, N Ciampini: Bioavailability of two formulations of acetylsalicylic acid gums. Pharmazie 1992; 47; H8; 607-609 95 LL Christrup, MR Rassing: Chewing gum as a drug delivery system. II Influence of the formulation upon the rate of release of salicylamide. Farmaci Sci Ed 1988; 16; 1-5 LL Christrup, HR Angelo, J Bonde, F Kristensen, SN Rasmussen: Relative bioavailability of methadone hydrochloride administered in chewing gum and tablets. Acta Pharm Nord 1990; 2; 83-88 D Hodoba: Chewing can relieve sleepiness in a night of sleep deprivation. Sleep Res Online 1999; 2; 101-105 GH Kamimori, CS Karyekar, R Otterstetter, DS Cox, TJ Balkin, GL Belenky, ND Eddington: The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int J Pharmaceutics 2002; 234; 159-167 M Uhari, T Kontiokari, M Koskela, M Niemel: Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial. BMJ 1996; 313; 1180-1184 M Uhari, T Kontiokari, M Niemel: A novel use of xylitol sugar in preventing acute otitis media. Pediatrics 1998; 102; 4; G Skofitsch, F Lembeck: Serum levels of dimenhydrinate. Drug Res 1983; 33; 1674-1676 LL Christrup, J Bonde, SN Rasmussen, MR Rassing: Relative bioavailability of verapamil hydrochloride administered in tablets and chewing gum. Acta Pharm Nord 1990; 2; 371-376. D Simons, P Baker, D Knott, S Rush, T Briggs, EAM Kidd, D Beighton: Attitudes of carers and the elderly occupants of residential homes to antimicrobial chewing gum as an aid to oral health. Br Dent J 1999; 187; 11; D Simons, P Baker, D Knott, S Rush, T Briggs, EAM Kidd, D Beighton: Antimicrobial chewing gum for the elderly in residential homes. Br Dent J 1999; 187; 11; Data on file, Fertin Pharma 2002 106 A Gray, MM Ferguson: The use of low-tack chewing gum for individuals wearing orthodontic appliances. Austr Dent J 1996; 41; 373-376 TM Graber, TP Muller, VD Bhatia: The effect of xylitol gum and rinses on plaque acidogenesis in patients with fixed orthodontoc appliances. Swed Dent J Suppl 1982; 15; 41-55.

Dimenhydrinate children

Blood pressure machine adult's and child's cuff ; Otoscope Ophthalmoscope Stethoscope If these instruments are not available, physicians should bring their own ; Anaphylactic kits with preloaded epinephrine and oral antihistamines. Make sure these kits are placed at both swim and canoe docks in case a camper has a bee-sting allergy An emergency kit that can be locked in a cupboard should include epinephrine that is not outdated and injectable dimenhydrinate, diazepam, and morphine and estradiol. 1. Stimulus lger modr Recommandation dimenhydrinate Solutions de rechange mclizine, promthazine 2. Stimulus intense Recommandation - promthazine avec amphtamine Solutions de rechange dimenhydrinate, timbre de scopolamine.

Dimenhydrinate ingredients

These tests, however, have limitations: there may not be sufficient numbers of antibodies to be detectable by blood tests for up to weeks or months after hepatitis develops and famotidine.

Additional information including the time of the ingestion or dermal exposure, determination of the precise dose ingested, and the presence of co-ingestants Grade D ; . 3. Patients experiencing any changes in behavior other than mild drowsiness or mild stimulation should be referred to an emergency department. Examples of moderate to severe symptoms that warrant referral include but are not limited to ; agitation, staring spells, inconsolable crying, hallucinations, abnormal muscle movements, loss of consciousness, seizures, or respiratory depression Grade D ; . 4. For patients referred to the emergency department, transportation via ambulance should be considered based on several factors including the condition of the patient and the length of time it will take the patient to arrive at the emergency department Grade D ; . Diphenhydramine 5. If the patient has no symptoms, and more than 4 hours have elapsed between the time of ingestion and the call to the poison center, referral to an emergency department is not recommended. For dermal exposures, if the patient has no symptoms and it has been more than 8 hours since the diphenhydramine was thoroughly removed from the skin, referral to an emergency department is not recommended Grade D ; . 6. Patients with acute ingestions of less than a toxic dose, or chronic exposures to diphenhydramine with no or mild symptoms, can be observed at home with instructions to call the poison center back if symptoms develop or worsen. The poison center should consider making a follow-up call at approximately 4 hours after ingestion Grade D ; . Acute Exposures in Children Less Than 6 Years of Age 7. Children less than 6 years of age who ingest at least 7.5 mg kg should be referred to an emergency department Grade D ; . Acute Exposures in Patients 6 Years of Age and Older 8. Patients ingesting at least 7.5 mg kg or 300 mg whichever is less ; should be referred to an emergency department Grade D ; . Dimenhydrinate 9. If the patient has no symptoms, and more than 6 hours has elapsed between the time of ingestion and the call to the poison center, referral to an emergency department is not recommended Grade D ; . 10. Patients with acute ingestions of less than a toxic dose, or chronic exposures to dimenhydrinate with no or mild symptoms, can be observed at home with instructions to call the poison center back if symptoms develop or worsen. The.

2. From table 4, compute and interpret values of relative and attributable risk for the "total" group and fexofenadine and dimenhydrinate, because dimenhydrinate pregnancy. What can I take Safely with Warfarin? All are available without a prescription ; 1. Headache and Pain relief: Acetaminophen or TylenolTM Limit to 4 tablets of 500 mg each day, 6 tablets of 325 mg each day or 3 tablets of the Arthritis Formula 2. Constipation: MetamucilTM, CitrucelTM, SenokotTM 3. Stool Softener: Docusate Sodium Colace ; 4. Diarrhea: Imodium ADTM liquid or tablets generic loperamide ; 5. Nausea: DramamineTM dimenhydrinate ; 6. Heartburn: MylantaTM, MaaloxTM, Zantac or Pepcid 7. Gas relief: MyliconTM simethicone ; 8. Cold Symptoms: Stuffy nose decongestants: Sudafed pseudoephedrine ; Sneezing, runny nose watery eyes: Claritin loratidine ; , chlorpheniramine, Benadryl diphenhydramine ; . Cough suppressant: Robitussin DMTM or DelsymTM dextromethorphan ; IMPORTANT -1. Take warfarin at the same time each day. 2. Report for your blood test on the day your are told to go. 3. Watch for any signs of bleeding. 4. Do NOT take aspirin products ex. Pepto Bismol, ibuprofen and ibuprofen like drugs ; . 5. Keep diet the same okay to eat green vegetables but eat basically the same amount regularly, no large portions!! 6. Do not drink alcohol beer, wine or liquor ; . 7. Be careful and avoid accidents and injuries. Put pressure and ice on any cuts. 8. Inform the Pharmacist of: a. Starting or Stopping of any drug s ; Examples: antibiotics, regular medications, herbals and vitamins ; . b. Any eating or diet changes eating less food or eating more vegetables ; . c. Any fever, diarrhea or nausea or vomiting REMEMBER: Report any of the following to the pharmacist or your doctor. Cuts that will not stop bleeding Mouth bleeding Nosebleeds Headaches that will not go away Easy Bruising Bleeding gums Blood in bowel movements Blood in urine Black tarry stools Cough or vomiting up blood Abnormal vaginal bleeding Possible Pregnancy. 3. Results For the PCL task, the dependent variable was mean number of correct responses on the first 100 trials, analyzed in blocks of 20 trials Fig. 1A ; . Performance of the control group improved to near asymptote from the first to the second block and that of the schizophrenic group treated with atypical antipsychotic medications similarly showed the greatest improvement from the first to the second block. The schizophrenic group treated with typical antipsychotic medications showed little evidence of learning. A two-variable mixed design ANOVA revealed significant main effects of group, F 2, 69 ; 3.56, p 0.04, and trial block, F 4, 276 ; 5.90, p 0.001, but a nonsignificant interaction, F 8, 276 ; 1.51, p 0.10. Pairwise comparisons Newman Keuls ; of groups revealed that the control and atypical groups did not differ from each other but both differed from the typical group p 0.05 ; . Although the interaction was not significant, planned one-way ANOVA of the block effect for each group revealed significant effects for the control, F 4, 124 ; 3.67, p 0.01, and atypical groups, F 4, 76 ; 3.84, p 0.01, but not the and pseudoephedrine. When the following conditions exist, a Paramedic may administer Dimenhydrinate IV or IM, according to the following protocol. Indications Patient is experiencing extreme nausea, OR vomiting, OR motion sickness as a result of an underlining disease or prehospital administration of narcotics or other medications. Contraindications Absolute Contraindications 1. Decreased level of consciousness GCS 13 ; 2. Allergy to Dimenhydrinate Gravol or antihistamines 3. Overdose of antihistamines or any other anticholinergic medications or tricyclic antidepressants TCA ; . Relative Contraindications 1. Closed head injury 2. History of Epilepsy or seizure disorder. Procedure: 1. 2. 3. Administer 100% O2 and document vital signs. Initiate continuous cardiac monitoring and pulse oximetry if available ; . Initiate IV NS TKO if possible ; . Dilute Dimenhydrinate Gravol 10: 1 with Normal Saline or sterile water prior to IV administration. If given IM do not dilute. IMPROVING SELF REPORTS You have the right to have your pain treated. It is your responsibility to communicate where and how much pain you have to your health-care provider. Self report is the single most important piece of pain assessment. To improve your self reports, watch for pain triggers. Notice things that make your pain worse such as certain movements, fatigue, or worsening of other MS symptoms. Rate your pain on a scale of zero to 10 with zero no pain, and 10 worst pain ; . As you rate the pain, note any activities, time of day, where you are, and who you are with. Describe the pain sharp, achy, stinging, etc. ; and what you did about it. It is wise to know what medications you are taking, and to learn the names and the side effects. Ask about the best time to take each one and what it is expected to do for you. Be an advocate in your own pain management. Always remember that pain is what the person experiencing the pain says it is. This will help you and your health-care provider treat your pain appropriately. As being histamine H1-receptor antagonists. Both promethazine and meclizine have strong anticholinergic properties and a long duration of action 1224 h ; . Dimenhydrinate, cyclizine, and cinnarizine are shorter acting and somewhat less effective than promethazine. All of these antihistaminic drugs cause drowsiness, promethazine and dimenhydrinate being the most sedative. Other side effects, dizziness, dry mouth, and blurred vision, which are attributable to the anticholinergic action of the drugs, occur but to a lesser extent than with scopolamine. The central sympathomimetic adrenergic ; agent d-amphetamine phosphate was used empirically in combination with scopolamine for motion sickness prophylaxis in World War II. Yet not until the 1960s was amphetamine by itself shown to increase tolerance to provocative motion and also to have an additive effect in therapeutic effectiveness when combined at a dose of 5 to mg with scopolamine or promethazine.105 A further benefit was a reduction of some of the side effects of scopolamine, notably drowsiness and performance decrement, but dry mouth was increased. Unfortunately, d-amphetamine is a potentially addictive drug and is liable to abuse, so its general use in motion sickness prophylaxis cannot be justified. Ephedrine 1530 mg ; is almost as good as d-amphetamine in enhancing the efficacy of antimotion sickness drugs and can be used in conjunction with scopolamine 0.6 mg ; or promethazine 25 mg ; when optimum protection of short or medium duration is required. The observation that electroencephalographic changes in acute motion sickness have features in common with those that occur in minor epilepsy led to the experimental evaluation of the analeptic drug phenytoin for motion sickness prophylaxis. At plasma concentrations of 10 to anticonvulsant therapeutic levels ; , the drug was highly effective in both laboratory and sea trials in increasing tolerance to provocative motion.106, 107 However, tests carried out 3 to 4 hours after a single 200-mg.

Dimenhydrinate dosing

Synopsis Biologists at the University of Liverpool have discovered how the plagues of the Middle Ages have made around 10% of Europeans resistant to HIV. Their research has been published in the Journal of Medical Genetics. Scientists have known for some time that these individuals carry a genetic mutation known as CCR5-32 ; that prevents the virus from entering the cells of the immune system but have been unable to account for the high levels of the gene in Scandinavia and relatively low levels in areas bordering the Mediterranean. They have also been puzzled by the fact that HIV emerged only recently and could not have played a role in raising the frequency of the mutation to the high levels found in some Europeans today. One of the researchers commented "the fact that the CCR5-32 mutation is restricted to Europe suggests that the plagues of the Middle Ages played a big part in raising the frequency of the mutation, because dimenhydrinate effects!

Points"bf U.S.Public Health Service and ditropan.
In addition, random testing is more likely to catch cannabis users, since thc metabolites have a longer duration in the body than those of other drugs.

Dimenhydrinate tablets

Nastech Pharmaceutical Bothell, WA ; is one of several specialty drug delivery companies working on "molecular biology-based" drug delivery, in contrast to more familiar avenues which Executive VP Tim Duffy terms "chemistry and physics-based drug delivery." Among Nastech's delivery platforms, which compete with injectable dosing, are intranasal administration and undisclosed ingredients that open up "tight junctions" between tissues, facilitating the entry of medicines into previously inaccessible tissues. Nastech has validated its nasal delivery method through partnerships with Proctor & Gamble for parathyroid hormone; used to treat hormone insufficiency ; , Amylin exenatide, branded as Bayetta; diabetes ; , Par calcitonin; osteoporosis ; , and an undisclosed Novo Nordisk application. For established drugs, nasal delivery provides the usual benefits compared with injection, albeit at the cost of lower bioavailability nothing beats, or probably will ever beat, injection for efficient drug delivery into the bloodstream. The arguments for injection alternatives vary: fear of needles, greater safety, efficacy, and convenience. In some inTIM DUFFY, NASTECH PHARMACEUTICAL stances, an intranasal or transdermal delivery method might create new demand for a drug, or even help developers obtain additional indications. Nastech's partnership with Amylin for exenatide is an example. More-convenient dosing through the nasal route is expected to provide greater convenience in situations where injection is inconvenient or impractical, a selling point in the age where "glycemic control" has become the mantra of diabetes management. And, a more convenient dosage form might make this medicine more attractive as an anti-obesity drug. Nastech's junction-opening delivery mechanism will benefit large drugs currently delivered by injection, or for which no delivery vehicle works. For example RNA interference RNAi ; , a type of gene therapy, is all the rage in drug discovery and development circles for its ability to knock out or "silence" genes, but notoriously difficult to deliver to the nuclei of cells, where target genes reside. By allowing oligonucleotides drugs to pass through cellular barriers, Nastech's "tight junction" technology might be the deal-maker for certain RNAi therapeutics. Nastech has RNAi programs in influenza and inflammatory diseases, and strategic licenses with RNAi specialty firm Alnylam Cambridge, MA ; and several academic medical institutions.